Skip to main content
VGTK
OTC Energy & Transportation

Viking Ozone Secures Formal French Attestation of Conformity for VKIN-300

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$0.039
Mkt Cap
$11.06M
52W Low
$0.017
52W High
$0.055
52W Position info
128% above low
Off High info
29% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

VGTK has more than doubled off its 52-week low of $0.017.

Summary

Viking Ozone received formal French Attestation of Conformity No. 41506-0 for its VKIN-300 medical waste treatment unit on October 28, 2026, valid through October 27, 2031. The certificate clears the regulatory hurdle for French commercialization, but the company reports no binding customer orders yet.


Key Events · Product Development and Regulatory · VGTK

  • French Attestation of Conformity Issued

    LNE issued Attestation No. 41506-0 on October 28, 2026 for the VKIN 300 SD disinfection pretreatment unit, confirming compliance with French standard NF X 30-503-1:2024.

  • Certificate Terms and Validity Window

    The attestation is effective October 28, 2026 and valid through October 27, 2031, may be renewed only once, and can be called into question if product requirements change or the equipment is modified. Certified parameters are ozone at a minimum average 3,500 ppm per 45-minute cycle.

  • No Revenue or Orders Attached

    The filing states commercial deployment remains subject to regulatory, site-specific, installation and operating approvals plus financing, manufacturing capacity and customer demand, with no assurance the attestation results in sales or revenues.

  • Follows October 5 Regulatory Amendment

    Completes the path opened when France incorporated NF X30-503-1:2024 into its rules on October 5, 2026, after which LNE's Technical Committee review was set for October 14, 2026 and documentation expected by end-October.


Analysis · VGTK · Energy & Transportation

The French conformity attestation had been the gate blocking VKIN-300 commercialization in France, and it is now issued rather than pending. That converts a years-long testing and regulatory process into a sellable product claim for healthcare and waste-management buyers. What it does not do is generate revenue: the filing explicitly states there are no binding customer commitments and that deployment still depends on financing, manufacturing capacity and demand. For a company of this size, the attestation is the necessary precondition for any French revenue, so the next real test is purchase orders, not the certificate itself.

How filings like this one have moved

In the 30 days to Nov 3, 2026, 32.3% of the 2077 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VGTK was trading at $0.04 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $11.1M. The 52-week trading range was $0.02 to $0.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VGTK - Latest Insights